Microfluidics for Positron Emission Tomography Probe Development-Reference-Cited by-同舟云学术

Microfluidics for Positron Emission Tomography Probe Development

Published:2010-07 Issue:4 Volume:9 Page:7290.2010.00027
ISSN:1536-0121
Container-title:Molecular Imaging
language:en
Short-container-title:Mol Imaging

Author:

Wang Ming-Wei¹,Lin Wei-Yu¹,Liu Kan¹,Masterman-Smith Michael¹,Shen Clifton Kwang-Fu¹

Affiliation:

1. From the Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA; Crump Institute for Molecular Imaging, Los Angeles, CA; and California Nanosystems Institute, Los Angeles, CA

Publisher

SAGE Publications

Subject

Condensed Matter Physics,Radiology Nuclear Medicine and imaging,Biomedical Engineering,Molecular Medicine,Biotechnology

Link

http://journals.sagepub.com/doi/pdf/10.2310/7290.2010.00027

Reference87 articles.

1. PET

2. Positron emission tomography provides molecular imaging of biological processes

3. Production of Non-standard PET Radionuclides and the Application of Radiopharmaceuticals Labeled with these Nuclides

4. 68Ga-PET Radiopharmacy: A Generator-Based Alternative to 18F-Radiopharmacy

5. Positron emission tomographic assessment of ?metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapy

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improved Chemical and Radiochemical Synthesis of Neuropeptide Y Y2 Receptor Antagonist N-Methyl-JNJ-31020028 and Preclinical Positron Emission Tomography Studies;Pharmaceuticals;2024-04-08

2. Automatic radioisotope manipulation for small amount of nuclear medicine using an EWOD device with a dimple structure;Royal Society Open Science;2021-05

3. Implementation of iMiDEV™, a new fully automated microfluidic platform for radiopharmaceutical production;Lab on a Chip;2021

4. Radiochemistry with Carbon‐11;Handbook of Radiopharmaceuticals;2020-12-21

5. Chemistry Considerations for the Clinical Translation of Oncology PET Radiopharmaceuticals;Molecular Pharmaceutics;2020-05-20